Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation—Where Are We Now?
Hemlata Patil,Sateesh Kumar Vemula,Sagar Narala,Preethi Lakkala,Siva Ram Munnangi,Nagarjuna Narala,Miguel O. Jara,Robert O. Williams,Hibreniguss Terefe,Michael A. Repka
DOI: https://doi.org/10.1208/s12249-024-02749-2
IF: 3.3
2024-02-16
AAPS PharmSciTech
Abstract:Hot-melt extrusion (HME) is a globally recognized, robust, effective technology that enhances the bioavailability of poorly soluble active pharmaceutical ingredients and offers an efficient continuous manufacturing process. The twin-screw extruder (TSE) offers an extremely resourceful customizable mixer that is used for continuous compounding and granulation by using different combinations of conveying elements, kneading elements (forward and reverse configuration), and distributive mixing elements. TSE is thus efficiently utilized for dry, wet, or melt granulation not only to manufacture dosage forms such as tablets, capsules, or granule-filled sachets, but also for designing novel formulations such as dry powder inhalers, drying units for granules, nanoextrusion, 3D printing, complexation, and amorphous solid dispersions. Over the past decades, combined academic and pharmaceutical industry collaborations have driven novel innovations for HME technology, which has resulted in a substantial increase in published articles and patents. This article summarizes the challenges and models for executing HME scale-up. Additionally, it covers the benefits of continuous manufacturing, process analytical technology (PAT) considerations, and regulatory requirements. In summary, this well-designed review builds upon our earlier publication, probing deeper into the potential of twin-screw extruders (TSE) for various new applications. Graphical
pharmacology & pharmacy